ES2071685T3 - Derivados de ciclohexanacetamida. - Google Patents

Derivados de ciclohexanacetamida.

Info

Publication number
ES2071685T3
ES2071685T3 ES90100935T ES90100935T ES2071685T3 ES 2071685 T3 ES2071685 T3 ES 2071685T3 ES 90100935 T ES90100935 T ES 90100935T ES 90100935 T ES90100935 T ES 90100935T ES 2071685 T3 ES2071685 T3 ES 2071685T3
Authority
ES
Spain
Prior art keywords
hydrogen
aryl
rent
lower rent
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90100935T
Other languages
English (en)
Inventor
Gary Lee Olson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2071685T3 publication Critical patent/ES2071685T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Packging For Living Organisms, Food Or Medicinal Products That Are Sensitive To Environmental Conditiond (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

[(5-OXO-2-PIRROLIDINILO)METILO] CICLOHEXANOACETAMIDAS DE LA FORMULA EN DONDE R1 ES HIDROGENO, ALQUILO INFERIOR O ARILO ALQUILO INFERIOR; R2 ES HIDROGENO, ALQUILO INFERIOR, ARILO, ARILO ALQUILO INFERIOR, EN DONDE R5 Y R6 SON HIDROGENO, ALQUILO INFERIOR O ARILO ALQUILO INFERIOR; R3 Y R4, INDEPENDIENTEMENTE, SON HIDROGENO, ALQUILO INFERIOR O ARILO ALQUILO INFERIOR; Y ENANTIOMEROS, DIASTOMEROS Y RACEMATOS DE ELLOS, Y, CUANDO R2 ES SALES DE ADICION ACIDA FARMACEUTICAMENTE ACEPTABLES DE ELLOS EXHIBEN ACTIVIDAD DE MEJORA COGNOSCITIVA Y ANTIAMNESICA Y SE USAN ADEMAS, POR EJEMPLO, EN TRATAMIENTO DE DEFICIENCIAS DE MEMORIA ASOCIADAS CON EL MAL DE ALZHEIMER O MEMORIA DAÑADA DEBIDO A LA EDAD.
ES90100935T 1989-01-17 1990-01-17 Derivados de ciclohexanacetamida. Expired - Lifetime ES2071685T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29772689A 1989-01-17 1989-01-17
US37764389A 1989-07-10 1989-07-10

Publications (1)

Publication Number Publication Date
ES2071685T3 true ES2071685T3 (es) 1995-07-01

Family

ID=26970288

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90100935T Expired - Lifetime ES2071685T3 (es) 1989-01-17 1990-01-17 Derivados de ciclohexanacetamida.

Country Status (16)

Country Link
EP (1) EP0381959B1 (es)
JP (1) JPH02229154A (es)
KR (1) KR900011759A (es)
AT (1) ATE122037T1 (es)
AU (1) AU625157B2 (es)
CA (1) CA2007732A1 (es)
DE (1) DE69019007T2 (es)
DK (1) DK0381959T3 (es)
ES (1) ES2071685T3 (es)
FI (1) FI900231A7 (es)
HU (1) HUT53607A (es)
IL (1) IL93051A0 (es)
MC (1) MC2081A1 (es)
NO (1) NO174386C (es)
NZ (1) NZ232112A (es)
PT (1) PT92874A (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4404848A1 (de) * 1994-02-16 1995-08-17 Hoechst Ag Substituierte Cyclohexanolester, ihre Verwendung zur Behandlung von Krankheiten und pharmazeutische Präparate
KR100395779B1 (ko) * 2001-05-25 2003-08-21 한국화학연구원 임의적으로 베타-위치가 치환된 알파-아릴알킬기의 제거를통해 3급 아미드 화합물로부터 2급 아미드 화합물을제조하는 방법
ES2865504T3 (es) 2008-10-16 2021-10-15 Univ Johns Hopkins Procedimientos y composiciones para la mejora de la función cognitiva
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
JP6433482B2 (ja) 2013-03-15 2018-12-05 エージンバイオ， インコーポレイテッド 認知機能を改善するための方法および組成物
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
WO2016191288A1 (en) 2015-05-22 2016-12-01 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1045043B (it) * 1975-08-13 1980-04-21 Isf Spa Derivati pirrolidinici
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
US4668687A (en) * 1984-07-23 1987-05-26 Bristol-Myers Company Psychogeriatric 1-(2-pyrimidinyl)piperazinyl derivatives of 1-pyrrolidin-2-ones
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
IT1224168B (it) * 1986-08-01 1990-09-26 Finanziaria R F Spa Ora Finanz Derivati del pirrolidin-2-one ad attivita' nootropa

Also Published As

Publication number Publication date
NO900234L (no) 1990-07-18
NO174386B (no) 1994-01-17
IL93051A0 (en) 1990-11-05
AU625157B2 (en) 1992-07-02
AU4798890A (en) 1990-07-26
EP0381959B1 (en) 1995-05-03
FI900231A7 (fi) 1990-07-18
NO174386C (no) 1994-04-27
EP0381959A1 (en) 1990-08-16
DE69019007T2 (de) 1995-09-14
JPH02229154A (ja) 1990-09-11
MC2081A1 (fr) 1991-01-07
HUT53607A (en) 1990-11-28
DK0381959T3 (da) 1995-09-04
ATE122037T1 (de) 1995-05-15
DE69019007D1 (de) 1995-06-08
CA2007732A1 (en) 1990-07-17
PT92874A (pt) 1990-07-31
HU900127D0 (en) 1990-03-28
NO900234D0 (no) 1990-01-16
NZ232112A (en) 1992-07-28
KR900011759A (ko) 1990-08-02
FI900231A0 (fi) 1990-01-16

Similar Documents

Publication Publication Date Title
ATE219766T1 (de) N-acylierte 4-aminopiperidin derivate als aktive bestandteile von peripher gefässerweiternden wikstoffen
NO302755B1 (no) Morfinan-derivater
DE69010139D1 (de) Haarkräftigungsmittel.
CA2040517A1 (en) 1,8-naphthyridin-2-one derivatives
NO941802L (no) Piperazinderivater
MY113693A (en) Erythromycin derivatives having an enterokinesis stimulating action
DK0646115T3 (da) Heterocykliske/cykliske aminderivater
LV11616A (lv) Cikliskie amidi ar fungicidu aktivitati
NO175259C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive triazolo-1,4-diazepinforbindelser
FI915920A0 (fi) Serotoninantagonister.
ES2071685T3 (es) Derivados de ciclohexanacetamida.
FI874865L (fi) Menetelmä lääkeaineena käyttökelpoisten imidatsolidinonijohdannaisten valmistamiseksi
ES2013035A6 (es) Un metodo para preparar derivados de acilfenol.
DE59409595D1 (de) Anellierte dihydropyridine und deren verwendung für die herstellung von pharmazeutischen zubereitungen
ES2097124T3 (es) Derivados del s-triazolo(3,4-i)purina.
AR246120A1 (es) Derivados de n'-alquil-n,n'diacilhidracina insecticidamente activos y composicion que los comprende.
ATE47135T1 (de) Antikonvulsive mittel.
ES2054186T3 (es) Composicion antihepatopatica.
DK0619817T3 (da) Hidtil ukendte farmaceutisk aktive flaviliumforbindelser
DE68912745D1 (de) Herstellung von optisch aktiven 2-Oxoimidazolidin-derivaten.
ES8707500A1 (es) Procedimiento para la obtencion de isocianatos piperidinicos.
TW360630B (en) A secoaporphine compounds on arrhythmia
KR840003633A (ko) 피리미돈 화합물의 제조방법
SU803381A1 (ru) 2-изопропилиденгидразино-4-фенил-5-[n-(2,6-диметоксипиримидил-4)сульфамоил фенилазо]тиазол, обладающий активностью в отношении candida albicans
TH13390A (es)

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 381959

Country of ref document: ES